Trial intelligence / Profile preview

Effect of Nicachet nicotine powder in pouch on oral mucosa and smoking cessation

2011-001764-21Phase 2Active

Sponsor
Magle Group
Start
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of nicotine in nicotine dependence, sponsored by Magle Group. Primary endpoint: Oral safety and tolerability. Started Apr 2011; status: active.

02

Drugs

nicotine
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on 2011-001764-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-001764-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call